BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8004668)

  • 1. Epstein-Barr virus strategy in normal and neoplastic B cells.
    Klein G
    Cell; 1994 Jun; 77(6):791-3. PubMed ID: 8004668
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus.
    Katsuki T; Hinuma Y; Yamamoto N; Abo T; Kumagai K
    Virology; 1977 Dec; 83(2):287-94. PubMed ID: 201086
    [No Abstract]   [Full Text] [Related]  

  • 3. The B cell-immortalizing functions of Epstein-Barr virus.
    Ring CJ
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():1-13. PubMed ID: 8113717
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus. Infection and tumour induction.
    Epstein MA
    Nature; 1986 Jun 12-18; 321(6071):653-4. PubMed ID: 3012366
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of measles and Epstein-Barr viruses in transformed human lymphocytes.
    Jankowski M; Sadowski W
    Acta Microbiol Pol; 1982; 31(1):15-21. PubMed ID: 6184957
    [No Abstract]   [Full Text] [Related]  

  • 6. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patients.
    Stewart JP; McGown AT; Prendiville J; Pettit GR; Fox BW; Arrand JR
    Cancer Chemother Pharmacol; 1993; 33(1):89-91. PubMed ID: 8269596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.
    Price AM; Luftig MA
    PLoS Pathog; 2015 Mar; 11(3):e1004656. PubMed ID: 25790223
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study of Epstein-Barr virus susceptibility in human tonsil B lymphocyte subpopulations].
    Harabuchi Y; Yamanaka N
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1799-811. PubMed ID: 2833594
    [No Abstract]   [Full Text] [Related]  

  • 10. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral latency and transformation: the strategy of Epstein-Barr virus.
    Klein G
    Cell; 1989 Jul; 58(1):5-8. PubMed ID: 2546674
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus silver anniversary.
    Lancet; 1989 May; 1(8648):1171-3. PubMed ID: 2566738
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.
    O'Reilly RJ; Small TN; Papadopoulos E; Lucas K; Lacerda J; Koulova L
    Springer Semin Immunopathol; 1998; 20(3-4):455-91. PubMed ID: 9870257
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases.
    Henle W; Henle G
    Ann N Y Acad Sci; 1980; 354():326-31. PubMed ID: 6261650
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality.
    Thorley-Lawson DA; Duca KA; Shapiro M
    Trends Immunol; 2008 Apr; 29(4):195-201. PubMed ID: 18328785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiology of Epstein-Barr virus-associated lymphomas.
    Rochford R; Mosier DE
    Clin Immunol Immunopathol; 1994 Jun; 71(3):256-9. PubMed ID: 8200127
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune surveillance against Epstein-Barr virus.
    Moss DJ; Burrows SR; Khanna R; Misko IS; Sculley TB
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus: adaptation to a life within the immune system.
    Masucci MG; Ernberg I
    Trends Microbiol; 1994 Apr; 2(4):125-30. PubMed ID: 8012755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and the immune system. Hide and seek.
    Cohen JI
    JAMA; 1997 Aug; 278(6):510-3. PubMed ID: 9256227
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
    Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
    J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.